Clinical Trials
3 trialsNCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
NCT00532818 2009-03-30
Hydralazine Valproate for Cervical Cancer
National Institute of Cancerología
Phase 3 Unknown
NCT00404326 2006-11-28
Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer
National Institute of Cancerología
Phase 2 Completed